A double blind, randomised, placebo controlled trial to evaluate the effect of Melatonin as an adjuvant agent at Induction of labour on the rate of induction of labour failure in healthy, pregnant women undergoing cervical ripening prior to induction of labour for prolonged pregnancy.

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 08 Aug 2019

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Melatonin (Primary) ; Oxytocin
Indications Labour induction
Focus Therapeutic Use

Most Recent Events

15 Jun 2018 Planned number of patients changed from 796 to 722.
15 Jun 2018 Status changed from not yet recruiting to recruiting.
20 Oct 2017 Planned initiation date changed from 1 Aug 2017 to 6 Nov 2017.

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login with a username/password associated to an account with a valid subscription
Contact your organization’s admin about adding this content to your AdisInsight subscription
Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Welcome to AdisInsight